Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Is atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers?

Veil-Picard M, Soumagne T, Vongthilath R, Annesi-Maesano I, Guillien A, Laurent L, Andujar P, Roche N, Jouneau S, Cypriani B, Laplante JJ, Degano B, Dalphin JC.

Respir Res. 2019 Jun 17;20(1):124. doi: 10.1186/s12931-019-1082-2.

2.

[Spontaneous lung volume reduction following pneumonia in a patient with emphysema].

Bazin Y, Kerjouan M, Lederlin M, Brinchault G, Le Guillou L, Salé A, Jouneau S.

Rev Mal Respir. 2019 Jun 12. pii: S0761-8425(19)30133-0. doi: 10.1016/j.rmr.2019.03.009. [Epub ahead of print] French.

PMID:
31202604
3.

[Hypersensitivity pneumonitis presenting as acute respiratory distress syndrome].

Arnouat B, Léveiller G, Barbarot N, Kerjouan M, Lederlin M, Desrues B, Jouneau S.

Rev Mal Respir. 2019 Jun 12. pii: S0761-8425(18)31012-X. doi: 10.1016/j.rmr.2017.12.006. [Epub ahead of print] French.

PMID:
31202600
4.

Beyond silicosis, is the world failing on silica hazards?

Cavalin C, Lescoat A, Ballerie A, Belhomme N, Jégo P, Jouneau S, Lecureur V, Lederlin M, Paris C, Rosental PA.

Lancet Respir Med. 2019 May 17. pii: S2213-2600(19)30174-2. doi: 10.1016/S2213-2600(19)30174-2. [Epub ahead of print] No abstract available.

PMID:
31109828
5.

Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!

Jouneau S, Lederlin M, Vernhet L, Thibault R.

Eur Respir J. 2019 May 9;53(5). pii: 1900418. doi: 10.1183/13993003.00418-2019. Print 2019 May. No abstract available.

PMID:
31072876
6.

Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib.

Bellamri N, Morzadec C, Joannes A, Lecureur V, Wollin L, Jouneau S, Vernhet L.

Int Immunopharmacol. 2019 Jul;72:112-123. doi: 10.1016/j.intimp.2019.03.061. Epub 2019 Apr 8.

PMID:
30974282
7.

A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone: A French Ancillary Study of PASSPORT.

Jouneau S, Gamez AS, Traclet J, Nunes H, Marchand-Adam S, Kessler R, Israël-Biet D, Borie R, Strombom I, Scalori A, Crestani B, Valeyre D, Cottin V.

Respiration. 2019 Apr 9:1-10. doi: 10.1159/000496735. [Epub ahead of print]

PMID:
30965332
8.

Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation.

Maher TM, Lancaster LH, Jouneau S, Morrison L, Lederer DJ, Molina-Molina M, Bendstrup E, Kirchgaessler KU, Gilberg F, Axmann J, Petzinger U, Noble PW.

Ann Am Thorac Soc. 2019 Apr 5. doi: 10.1513/AnnalsATS.201810-720RL. [Epub ahead of print] No abstract available.

PMID:
30950636
9.

What are the best indicators to assess malnutrition in idiopathic pulmonary fibrosis patients? A cross-sectional study in a referral center.

Jouneau S, Kerjouan M, Rousseau C, Lederlin M, Llamas-Guttierez F, De Latour B, Guillot S, Vernhet L, Desrues B, Thibault R.

Nutrition. 2019 Jun;62:115-121. doi: 10.1016/j.nut.2018.12.008. Epub 2018 Dec 19.

PMID:
30878815
10.

Women and COPD: do we need more evidence?

Gut-Gobert C, Cavaillès A, Dixmier A, Guillot S, Jouneau S, Leroyer C, Marchand-Adam S, Marquette D, Meurice JC, Desvigne N, Morel H, Person-Tacnet C, Raherison C.

Eur Respir Rev. 2019 Feb 27;28(151). pii: 180055. doi: 10.1183/16000617.0055-2018. Print 2019 Mar 31. Review.

11.

[Targeted screening of COPD in primary care: Feasibility and effectiveness].

Chapron A, Pelé F, Andres É, Fiquet L, Laforest C, Veislinger A, Fougerou C, Turmel V, Fouchard J, Yourish B, Oumari S, Allory E, Banâtre A, Schweyer FX, Pommier J, Brinchault G, Guillot S, Laviolle B, Jouneau S.

Rev Mal Respir. 2019 Feb;36(2):162-170. doi: 10.1016/j.rmr.2018.08.023. Epub 2019 Jan 24. French.

PMID:
30686560
12.

Interstitial Lung Disease and Mediastinal Lymph Nodes: A Computed Tomography-based Biomarker beyond Nosological and Etiological Borders?

Lescoat A, Lederlin M, Ballerie A, Belhomme N, Cavalin C, Jégo P, Jouneau S.

Am J Respir Crit Care Med. 2019 Apr 15;199(8):1038-1040. doi: 10.1164/rccm.201811-2123LE. No abstract available.

13.

Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.

Richeldi L, Varone F, Bergna M, de Andrade J, Falk J, Hallowell R, Jouneau S, Kondoh Y, Morrow L, Randerath W, Strek M, Tabaj G.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180074. doi: 10.1183/16000617.0074-2018. Print 2018 Dec 31. Review.

14.

[Features distinguishing ornithosis from avian acute hypersensitivity pneumonitis - a retrospective analysis].

Jézéquel A, Jouneau S, Bouju P, Letheulle J, Kerjouan M, Gacouin A.

Rev Mal Respir. 2019 Mar;36(3):298-306. doi: 10.1016/j.rmr.2017.11.013. Epub 2018 Nov 22. French.

PMID:
30473450
15.

Efferocytosis capacities of blood monocyte-derived macrophages in systemic sclerosis.

Ballerie A, Lescoat A, Augagneur Y, Lelong M, Morzadec C, Cazalets C, Jouneau S, Fardel O, Vernhet L, Jégo P, Lecureur V.

Immunol Cell Biol. 2019 Mar;97(3):340-347. doi: 10.1111/imcb.12217. Epub 2018 Dec 13.

16.

Prevalence and risk factors of chronic obstructive pulmonary disease in dairy farmers: AIRBAg study.

Jouneau S, Marette S, Robert AM, Gouyet T, Guillot S, Chapron A, Mailloux C, Desrues B, Viel JF; AIRBAG research group.

Environ Res. 2019 Feb;169:1-6. doi: 10.1016/j.envres.2018.10.026. Epub 2018 Oct 27.

PMID:
30399467
17.

M1/M2 polarisation state of M-CSF blood-derived macrophages in systemic sclerosis.

Lescoat A, Ballerie A, Jouneau S, Fardel O, Vernhet L, Jego P, Lecureur V.

Ann Rheum Dis. 2018 Sep 29. pii: annrheumdis-2018-214333. doi: 10.1136/annrheumdis-2018-214333. [Epub ahead of print] No abstract available.

PMID:
30269049
18.

Sarcoidosis in Patients with Antisynthetase Syndrome: Presentation and Outcome.

Couture P, Brillet PY, Varin S, Le Goff B, Meyer A, Sibilia J, Jouneau S, Valeyre D, Hervier B, Uzunhan Y.

J Rheumatol. 2018 Aug;45(9):1296-1300. doi: 10.3899/jrheum.171098. Epub 2018 Jul 1.

PMID:
29961694
19.

Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS.

Grégoire M, Uhel F, Lesouhaitier M, Gacouin A, Guirriec M, Mourcin F, Dumontet E, Chalin A, Samson M, Berthelot LL, Tissot A, Kerjouan M, Jouneau S, Le Tulzo Y, Tarte K, Zmijewski JW, Tadié JM.

Eur Respir J. 2018 Aug 2;52(2). pii: 1702590. doi: 10.1183/13993003.02590-2017. Print 2018 Aug.

20.

Factors determining the exposure of dairy farmers to thoracic organic dust.

Pfister H, Madec L, Cann PL, Costet N, Chouvet M, Jouneau S, Vernhet L.

Environ Res. 2018 Aug;165:286-293. doi: 10.1016/j.envres.2018.04.031. Epub 2018 May 11.

21.

Radiology residents' skill level in chest x-ray reading.

Fabre C, Proisy M, Chapuis C, Jouneau S, Lentz PA, Meunier C, Mahé G, Lederlin M.

Diagn Interv Imaging. 2018 Jun;99(6):361-370. doi: 10.1016/j.diii.2018.04.007. Epub 2018 May 4.

22.

Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study.

Belhomme N, Jouneau S, Bouzillé G, Decaux O, Lederlin M, Guillot S, Perlat A, Jégo P.

PLoS One. 2018 Apr 11;13(4):e0193122. doi: 10.1371/journal.pone.0193122. eCollection 2018.

23.

Distinct Properties of Human M-CSF and GM-CSF Monocyte-Derived Macrophages to Simulate Pathological Lung Conditions In Vitro: Application to Systemic and Inflammatory Disorders with Pulmonary Involvement.

Lescoat A, Ballerie A, Augagneur Y, Morzadec C, Vernhet L, Fardel O, Jégo P, Jouneau S, Lecureur V.

Int J Mol Sci. 2018 Mar 17;19(3). pii: E894. doi: 10.3390/ijms19030894.

24.

Phagocytosis depends on TRPV2-mediated calcium influx and requires TRPV2 in lipids rafts: alteration in macrophages from patients with cystic fibrosis.

Lévêque M, Penna A, Le Trionnaire S, Belleguic C, Desrues B, Brinchault G, Jouneau S, Lagadic-Gossmann D, Martin-Chouly C.

Sci Rep. 2018 Mar 9;8(1):4310. doi: 10.1038/s41598-018-22558-5.

25.

[Interstitial lung disease and pancreatic cancer: Series of two cases].

Heraudeau A, Ricordel C, Sale A, Lederlin M, Kerjouan M, De Latour B, Llamas-Guttierez F, Desrues B, Jouneau S.

Rev Mal Respir. 2018 Jan;35(1):78-82. doi: 10.1016/j.rmr.2017.10.009. French.

PMID:
29398155
26.

Pulmonary arterial hypertension in four patients treated by leflunomide.

Coirier V, Lescoat A, Chabanne C, Fournet M, Coiffier G, Jouneau S, Polard E, Jégo P.

Joint Bone Spine. 2018 Dec;85(6):761-763. doi: 10.1016/j.jbspin.2017.12.014. Epub 2018 Jan 9.

27.

Pirfenidone photosensitization in patients with idiopathic pulmonary fibrosis: a case series.

Droitcourt C, Adamski H, Polat A, Polard E, Kerjouan M, Arnouat B, Le Garrec M, Oger E, Dupuy A, Jouneau S.

Br J Dermatol. 2018 Mar;178(3):e222-e223. doi: 10.1111/bjd.16016. Epub 2018 Jan 30. No abstract available.

28.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. 2017 update. Full-length update].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 21. pii: S0761-8425(17)30209-7. doi: 10.1016/j.rmr.2017.07.018. [Epub ahead of print] French. No abstract available.

29.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Full-length version.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):900-968. doi: 10.1016/j.rmr.2017.07.017. Epub 2017 Sep 20. No abstract available.

PMID:
28939155
30.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Short-length version.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):852-899. doi: 10.1016/j.rmr.2017.07.019. Epub 2017 Sep 20. No abstract available.

PMID:
28939154
31.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Short-length version].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 18. pii: S0761-8425(17)30211-5. doi: 10.1016/j.rmr.2017.07.020. [Epub ahead of print] French. No abstract available.

PMID:
28935497
32.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 19. pii: S0761-8425(17)30212-7. doi: 10.1016/j.rmr.2017.07.021. [Epub ahead of print] French. No abstract available.

PMID:
28935496
33.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):834-851. doi: 10.1016/j.rmr.2017.07.022. Epub 2017 Sep 19. No abstract available.

PMID:
28935495
34.

[Pulmonary nocardiosis with cerebral abscesses mimicking metastatic lung cancer: Three cases and a review of literature].

Fourrier A, Kerjouan M, Piau C, Lentz PA, Ricordel C, Léna H, Corre R, Desrues B, Jouneau S.

Rev Mal Respir. 2017 Nov;34(9):1016-1021. doi: 10.1016/j.rmr.2017.08.002. Epub 2017 Sep 15. Review. French.

PMID:
28918971
35.

Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries.

Maher TM, Molina-Molina M, Russell AM, Bonella F, Jouneau S, Ripamonti E, Axmann J, Vancheri C.

BMC Pulm Med. 2017 Sep 15;17(1):124. doi: 10.1186/s12890-017-0468-5.

36.

Case-Finding for Persistent Airway Obstruction in Farmers: A Questionnaire With Optimal Diagnosis Criteria.

Guillien A, Soumagne TE, Puyraveau M, Berger P, Guillot SL, Rannou F, Jouneau S, Mauny FJ, Laplante JJ, Dalphin JC, Degano B.

Am J Prev Med. 2017 Dec;53(6):837-844. doi: 10.1016/j.amepre.2017.06.031. Epub 2017 Aug 14.

PMID:
28818418
37.

Granulometry, microbial composition and biological activity of dusts collected in French dairy farms.

Pfister H, Morzadec C, Le Cann P, Madec L, Lecureur V, Chouvet M, Jouneau S, Vernhet L.

Environ Res. 2017 Oct;158:691-702. doi: 10.1016/j.envres.2017.07.025. Epub 2017 Jul 20.

PMID:
28735230
38.

New guidelines for acute COPD exacerbations.

Jouneau S, Chabot F, Roche N.

Rev Mal Respir. 2017 Apr;34(4):279-281. doi: 10.1016/j.rmr.2017.05.001. No abstract available.

PMID:
28599784
39.

Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Société de pneumologie de langue française (summary).

Jouneau S, Dres M, Guerder A, Bele N, Bellocq A, Bernady A, Berne G, Bourdin A, Brinchault G, Burgel PR, Carlier N, Chabot F, Chavaillon JM, Cittee J, Claessens YE, Delclaux B, Deslée G, Ferré A, Gacouin A, Girault C, Ghasarossian C, Gouilly P, Gut-Gobert C, Gonzalez-Bermejo J, Jebrak G, Le Guillou F, Léveiller G, Lorenzo A, Mal H, Molinari N, Morel H, Morel V, Noel F, Pégliasco H, Perotin JM, Piquet J, Pontier S, Rabbat A, Revest M, Reychler G, Stelianides S, Surpas P, Tattevin P, Roche N.

Rev Mal Respir. 2017 Apr;34(4):282-322. doi: 10.1016/j.rmr.2017.03.034. Epub 2017 May 25.

PMID:
28552256
40.

[Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Comparison of DETECT algorithm to decisions of a multidisciplinary team, in a competence centre].

Coirier V, Lescoat A, Fournet M, Cazalets C, Coiffier G, Jouneau S, Chabanne C, Jégo P.

Rev Med Interne. 2017 Aug;38(8):502-507. doi: 10.1016/j.revmed.2017.04.005. Epub 2017 May 22. French.

PMID:
28545856
41.

[Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Société de Pneumologie de Langue Française (Argumentary)].

Jouneau S, Roche N.

Rev Mal Respir. 2017 Apr;34(4):323-326. doi: 10.1016/j.rmr.2017.03.001. Epub 2017 May 12. Review. French. No abstract available.

PMID:
28502518
42.

[Oxygen therapy for acute COPD exacerbations].

Jouneau S.

Rev Mal Respir. 2017 Apr;34(4):427-429. doi: 10.1016/j.rmr.2017.03.031. Epub 2017 May 10. French. No abstract available.

PMID:
28502369
43.

Acute eosinophilic pneumonia following artenimol-piperaquine exposure.

Fourmont L, Revest M, Polard E, Lederlin M, Delaval P, Desrues B, Tattevin P, Jouneau S.

J Travel Med. 2017 Sep 1;24(5). doi: 10.1093/jtm/tax023.

PMID:
28499010
44.

Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.

Jouneau S, Ballerie A, Kerjouan M, Demant X, Blanchard E, Lederlin M.

Eur Respir J. 2017 May 11;49(5). pii: 1700407. doi: 10.1183/13993003.00407-2017. Print 2017 May. No abstract available.

45.

[Triggering factors of acute COPD exacerbations].

Jouneau S.

Rev Mal Respir. 2017 Apr;34(4):343-348. doi: 10.1016/j.rmr.2017.03.005. Epub 2017 May 2. Review. French. No abstract available.

46.

Skin manifestations among GATA2-deficient patients.

Polat A, Dinulescu M, Fraitag S, Nimubona S, Toutain F, Jouneau S, Poullot E, Droitcourt C, Dupuy A.

Br J Dermatol. 2018 Mar;178(3):781-785. doi: 10.1111/bjd.15548. Epub 2017 Oct 11.

47.

CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis.

Lescoat A, Lecureur V, Roussel M, Sunnaram BL, Ballerie A, Coiffier G, Jouneau S, Fardel O, Fest T, Jégo P.

Clin Rheumatol. 2017 Jul;36(7):1649-1654. doi: 10.1007/s10067-017-3597-6. Epub 2017 Mar 14.

PMID:
28293753
48.

Soluble CD14 acts as a DAMP in human macrophages: origin and involvement in inflammatory cytokine/chemokine production.

Lévêque M, Simonin-Le Jeune K, Jouneau S, Moulis S, Desrues B, Belleguic C, Brinchault G, Le Trionnaire S, Gangneux JP, Dimanche-Boitrel MT, Martin-Chouly C.

FASEB J. 2017 May;31(5):1891-1902. doi: 10.1096/fj.201600772R. Epub 2017 Jan 25.

49.

Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis.

Borie R, Tabèze L, Thabut G, Nunes H, Cottin V, Marchand-Adam S, Prevot G, Tazi A, Cadranel J, Mal H, Wemeau-Stervinou L, Bergeron Lafaurie A, Israel-Biet D, Picard C, Reynaud Gaubert M, Jouneau S, Naccache JM, Mankikian J, Ménard C, Cordier JF, Valeyre D, Reocreux M, Grandchamp B, Revy P, Kannengiesser C, Crestani B.

Eur Respir J. 2016 Dec;48(6):1721-1731. doi: 10.1183/13993003.02115-2015. Epub 2016 Nov 11.

50.

Association of pulmonary alveolar proteinosis and fibrosis: patient with GATA2 deficiency.

Ballerie A, Nimubona S, Meunier C, Gutierrez FL, Desrues B, Delaval P, Jouneau S.

Eur Respir J. 2016 Nov;48(5):1510-1514. doi: 10.1183/13993003.00252-2016. Epub 2016 Oct 20. No abstract available.

Supplemental Content

Loading ...
Support Center